Cefilavancin

With its broad-spectrum activity, Cefilavancin effectively combats drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and many other Gram-positive organisms. Cefilavancin works by inhibiting cell wall synthesis, leading to bacterial cell death.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R2025

CAS No:1393900-12-3

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C87H95Cl3N16O28S2
M.W/Mr.
1983.26

Cefilavancin is a synthetic glycopeptide antibiotic compound, structurally related to vancomycin analogs, and is primarily characterized by its complex peptide backbone and unique side chain modifications. As a member of the glycopeptide class, it is notable for its ability to interact with bacterial cell wall biosynthesis pathways, making it a valuable tool in the study of antimicrobial mechanisms and resistance. Its distinctive molecular architecture and functional groups enable researchers to explore structure-activity relationships within peptide-based antibiotics, advancing understanding in the field of microbiology and medicinal chemistry. The compound's robust biochemical profile positions it as a key resource for laboratories engaged in antimicrobial research, peptide chemistry, and the development of next-generation anti-infective agents.

Antimicrobial Mechanism Studies: Cefilavancin serves as an important reference compound for investigating the inhibition of cell wall biosynthesis in Gram-positive bacteria. By binding to the D-Ala-D-Ala termini of peptidoglycan precursors, it disrupts the cross-linking process essential for bacterial cell wall integrity. This mechanism underpins its utility in elucidating the molecular basis of glycopeptide antibiotic action, facilitating the characterization of resistance mutations and the identification of novel antibacterial targets. Researchers utilize the compound to dissect the interaction between glycopeptide scaffolds and bacterial enzymes, contributing to the broader understanding of antimicrobial pharmacodynamics.

Peptide Antibiotic Structure-Activity Relationship (SAR) Analysis: The unique modifications present in cefilavancin, including its lipophilic side chains and glycosylation patterns, make it a valuable model for structure-activity relationship studies within the glycopeptide antibiotic class. By comparing its biochemical properties and functional outcomes to those of related analogs, scientists can delineate the contributions of specific molecular features to antimicrobial potency, spectrum of activity, and resistance evasion. Such SAR analyses inform the rational design of next-generation peptide antibiotics with improved pharmacological profiles.

Analytical Method Development: Owing to its defined peptide structure and distinctive functional groups, cefilavancin is widely employed as a reference standard in the development and validation of analytical techniques. High-performance liquid chromatography (HPLC), mass spectrometry, and related bioanalytical methods rely on this compound for calibration, method optimization, and quality control in research settings. Its presence enables accurate quantification and identification of glycopeptide antibiotics in complex biological samples, supporting pharmacokinetic and stability studies.

Resistance Mechanism Elucidation: The ongoing emergence of glycopeptide-resistant bacterial strains has intensified interest in the molecular underpinnings of resistance. Cefilavancin is used in laboratory models to probe the adaptive responses of bacteria, such as altered target site binding, cell wall thickening, and efflux mechanisms. By exposing microbial cultures to this compound, researchers can monitor genetic and phenotypic changes that confer reduced susceptibility, thereby informing surveillance efforts and the development of novel countermeasures against resistant pathogens.

Peptide Synthesis and Modification Research: The intricate architecture of cefilavancin provides a template for synthetic peptide chemists exploring new strategies in glycopeptide assembly and modification. Its complex side chains and glycosylation motifs serve as benchmarks for developing advanced solid-phase synthesis techniques, chemoenzymatic approaches, and site-specific functionalization protocols. Studies utilizing this compound help refine synthetic methodologies and expand the toolkit available for constructing bioactive peptide frameworks, ultimately supporting innovation in antibiotic discovery and peptide-based drug design.

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Analysis ServicesEpitope Mapping ServicesPeptide Modification ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisCustom Conjugation ServicePeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers